Form 4 holding
Chief Financial Officer
Rapport Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 10,000
- Estimated value
- $99,800
- Report date
- 13 Mar 2025
- Price
- $9.98
- Ownership
- Direct
Troy A. Ignelzi - Chief Financial Officer at Rapport Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- RAPP on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Troy A. Ignelzi since 14 Aug 2025
Reported holdings for Troy A. Ignelzi in Rapport Therapeutics, Inc.
Form 4 holding
Chief Financial Officer
Rapport Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 148,000
- Estimated value
- Report date
- 02 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Troy A. Ignelzi in Rapport Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.